|
FY2026
12 months to Jun 30, 2026
|
|
|---|---|
| Cash flows from operating activities: | |
| Net income | |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| Income earned on marketable securities held in Trust Account | |
| Formation costs paid by Sponsor | |
| Changes in operating assets and liabilities | |
| Accrued expenses | |
| Net cash used in operating activities | |
| Cash Flows from Investing Activity | |
| Purchase of marketable securities held in Trust Account | |
| Net cash used in investing activity | |
| Cash Flows from Financing Activities | |
| Proceeds from sale of public units through public offerings, net of underwriters’ discount | |
| Proceeds from ordinary shares issued in private placement | |
| Payment of offering costs | |
| Net cash provided by financing activities | |
| Net change in cash | |
| Cash at the end of the period | |
| Supplemental disclosure of non-cash flow information: | |
| Deferred offering costs paid by Sponsor under the promissory note-related party | |
| Accretion of ordinary shares subject to redemption value | |
| Deferred underwriting commission accrued and offset against additional paid-in capital |
Loading...